Exicure, Inc. (NASDAQ:XCUR) Short Interest Down 17.3% in January

Exicure, Inc. (NASDAQ:XCUR) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 50,600 shares, a decrease of 17.3% from the December 31st total of 61,200 shares. Based on an average trading volume of 727,200 shares, the days-to-cover ratio is presently 0.1 days. Approximately 21.5% of the shares of the stock are sold short.

Exicure Stock Down 6.9 %

NASDAQ:XCUR opened at $10.73 on Thursday. Exicure has a twelve month low of $1.44 and a twelve month high of $36.00. The stock has a market cap of $28.01 million, a P/E ratio of -5.18 and a beta of 3.81. The business’s 50-day moving average price is $16.25 and its two-hundred day moving average price is $6.96.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.